Patent assignee · US · COMPANY

Cortex Pharmaceuticals, Inc.

15Patents
7Active
15Granted
38Portfolio score

Filing activity: Mar 7, 1994 → Jan 31, 2013 · 4 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US5567724A Alkaline and acid phosphatase inhibitors in treatment of neurological disorders Human Necessities 105 Expired
US5444042A Method of treatment of neurodegeneration with calpain inhibitors Human Necessities 31 Expired
US5736543A Benzoxazines for enhancing synaptic response Chemistry; Metallurgy 26 Expired
US8013003B2 Di-substituted amides for enhancing glutamatergic synaptic responses Chemistry; Metallurgy 20 Active
US5650409A Benzoyl piperidines/pyrrolidines for enhancing synaptic response Chemistry; Metallurgy 20 Expired
US6166008A Treatment of schizophrenia with ampakines and neuroleptics Human Necessities 14 Expired
US5985871A Benzoxazine compounds for enhancing synaptic response Human Necessities 3 Expired
US5622981A Use of metabotropic receptor agonists in progressive neurodegenerative diseases Human Necessities 3 Expired
US8119632B2 Bicyclic amide derivatives for enhancing glutamatergic synaptic responses Human Necessities 1 Active
US8642633B2 Di-substituted amides for enhancing glutamatergic synaptic responses Chemistry; Metallurgy 0 Active
US8404682B2 Di-substituted amides for enhancing glutamatergic synaptic responses Chemistry; Metallurgy 0 Active
US8168632B2 Bicyclic amide derivatives for the treatment of respiratory disorders Human Necessities 0 Active
US8263591B2 Bicyclic amides for enhancing glutamatergic synaptic responses Chemistry; Metallurgy 0 Active
US8507482B2 Bicyclic amide derivatives for enhancing glutamatergic synaptic responses Human Necessities 0 Active
US7799913B2 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses Chemistry; Metallurgy 0 Expired

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.